Novo's Diabetes Combo May Find Home With General Practitioners

Despite FDA skepticism about fixed dosing, advisory committee says there are patients and providers who will benefit.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America